Literature DB >> 13845470

[The increase of thrombin inhibitor in the blood after percutaneous administration of a heparinoid].

S WITTE, D BRESSEL.   

Abstract

Entities:  

Keywords:  HEPARIN/pharmacology; THROMBIN/antagonists

Mesh：

Substances：

Year:  1960        PMID： 13845470     DOI： 10.1007/bf01483764

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  8 in total

1.  [Clinical and experimental tests with hirudoid ointment].

Authors:  G CHYLA
Journal:  Dtsch Med Wochenschr       Date:  1954-02-26       Impact factor: 0.628

2.  [Clinical and experimental experience with hirudoid ointment].

Authors:  F HOLZKNECHT
Journal:  Schweiz Med Wochenschr       Date:  1954-02-20

3.  [Experimental studies on percutaneous efficacy of anticoagulative substances; potentiation of intravenously administered heparin by percutaneous hirudoid].

Authors:  J PICHOTKA; K MAYER
Journal:  Arzneimittelforschung       Date:  1954-04

4.  [Clinical application of hirudoid].

Authors:  K G EYSHOLDT
Journal:  Med Klin       Date:  1954-01-22

5.  [Separate determination of thrombin inhibitor and antithrombin; experimental basis and clinical use].

Authors:  S WITTE; P DIRNBERGER
Journal:  Schweiz Med Wochenschr       Date:  1954-07-17

6.  [Percutaneous influencing of the blood coagulation].

Authors:  G SCHIMERT; A STRUPPLER
Journal:  Munch Med Wochenschr       Date:  1951-02-09

7.  [Observations on the anticoagulant effect and use of hirudoid salve].

Authors:  E KAUTZSCH
Journal:  Dtsch Med Wochenschr       Date:  1950-11-10       Impact factor: 0.628

8.  [Attempts of prophylaxis of thromboembolism with hirudoid ointment].

Authors:  F SCHEDEL
Journal:  Dtsch Med Wochenschr       Date:  1952-05-23       Impact factor: 0.628
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.